Drugs Made In America Acquisition DMIIU Cash Flow Statement (2024-2026)

NASDAQ DMIIU
$10.23 +0.00 (+0.00%)
At close: Nov 3, 2026 · 4:00 PM EST
Reported Financials

Drugs Made In America Acquisition Quarterly Cash Flow Statement

Periods 6 quarters
Latest Jun 2026

Drugs Made In America Acquisition reported cash from operations of -$0.17M and free cash flow of -$0.17M for the quarter ended Jun 2026. This cash flow statement covers 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Drugs Made In America Acquisition Cash Flow Statement API

Pull Drugs Made In America Acquisition's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DMIIU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY